| Chemical & Physical Properties | |
|---|---|
| CAS Number | 3517-49-5 |
| Catalog No. | 2A-3179303 |
| Molecular Formula | C25H32O7 |
| Molecular Weight | 444.5 |
| PubChem ID | 134412647 |
| InChI | InChI=1S/C25H32O7/c1-14(26)31-13-21(30)25(32-15(2)27)10-8-19-18-6-5-16-11-17(28)7-9-23(16,3)22(18)20(29)12-24(19,25)4/h11,18-19,22H,5-10,12-13H2,1-4H3/t18-,19-,22+,23-,24-,25-/m0/s1 |
| InChI Key | KLIOCFXTENIYDT-AHLAAXOLSA-N |
| Related Products in Analytical Standards | ||
|---|---|---|
| Sitagliptin impurity H HCl | 1334244-24-4 | 2A-4178755 |
| Sitagliptin Impurity 10 | 1253056-01-7 | 2A-4178757 |
| Bortezomib impurity 2/(1S,2R)-Bortezomib | 1132709-16-0 | 2A-3179296 |
| Bortezomib Impurity 10 | 390800-88-1 | 2A-3179300 |
| bortezoMib iMpurity H | 1446194-56-4 | 2A-3179301 |
| Tranexamic acid impurity 2/Tranexamic EP Impurity C HCl/4-(aminomethyl)cyclohex-1-ene-1-carboxylic Acid hydrochloride | 1803601-44-6 | 2A-3179308 |
| EzetiMibe Dehydoxy IMpurity | 204589-58-2 | 2A-3179336 |
| EzetiMibe IMpurity 1 | 190595-66-5 | 2A-3179337 |
| Ezetimibe Impurity | 1510820-22-0 | 2A-3179341 |
| Daclatasvir impurity 15/N-[(1S)-1-[[(2S)-2-[5-[4’-[2-[(2S)-1-Acetyl-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-methyl ester carbamic acid | 2226541-13-3 | 2A-3179355 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS